Research. Discover. Cure.

The research will explore key challenges in cancer, from metastasis and treatment resistance to childhood tumours and the effects of cancer on the body.

The new laboratory will join IRB Barcelona's Aging and Metabolism research programme, expanding the Institute's capabilities in therapeutic discovery.

Researchers at IRB Barcelona will lead three of these awarded projects, tackling key challenges in metabolic disease, liver ageing, and stem cell dynamics. 

The team will receive €90,000 to investigate why malignant rhabdoid tumours can resist treatment.

The project brings together 25 partners across 8 countries and incorporates Almirall, Sanofi, and other pharmaceutical companies to provide feedback and evaluate the practical usefulness of the platform in industrial settings.